Cargando…

Differential impact of individual autonomic domains on clinical outcomes in Parkinson’s disease

INTRODUCTION: While autonomic failure is a well-known prognostic factor for more aggressive disease progression in Parkinson’s disease (PD), with a three- to sevenfold higher risk of dementia and death within 10 years after the diagnosis, the individual impact of cardiovascular, gastrointestinal, ur...

Descripción completa

Detalles Bibliográficos
Autores principales:	Longardner, Katherine, Merola, Aristide, Litvan, Irene, De Stefano, Alberto Maria, Maule, Simona, Vallelonga, Fabrizio, Lopiano, Leonardo, Romagnolo, Alberto
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2022
Materias:	Original Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9201260/ https://www.ncbi.nlm.nih.gov/pubmed/35708788 http://dx.doi.org/10.1007/s00415-022-11221-9

Ejemplares similares

Burden of caregiving for cardiovascular dysautonomia in Parkinson’s disease
por: Ledda, Claudia, et al.
Publicado: (2022)

Orthostatic Hypotension Is Associated With Cognitive Decline in Parkinson Disease
por: Longardner, Katherine, et al.
Publicado: (2020)

Machine learning applied to ambulatory blood pressure monitoring: a new tool to diagnose autonomic failure?
por: Vallelonga, Fabrizio, et al.
Publicado: (2022)

Pisa Syndrome in Parkinson's Disease Is Associated With Specific Cognitive Alterations
por: Artusi, Carlo Alberto, et al.
Publicado: (2019)

Deep Brain Stimulation Outcomes in Parkinson's Disease Patients with Cognitive Impairment: Implications and Considerations
por: Romagnolo, Alberto, et al.
Publicado: (2023)

COVID-19 in Parkinson's disease: Report on prevalence and outcome
por: Artusi, Carlo Alberto, et al.
Publicado: (2020)

Association of Orthostatic Hypotension With Cerebral Atrophy in Patients With Lewy Body Disorders
por: Pilotto, Andrea, et al.
Publicado: (2021)

Gene Therapy in Movement Disorders: A Systematic Review of Ongoing and Completed Clinical Trials
por: Merola, Aristide, et al.
Publicado: (2021)

COVID-19 and Parkinson’s Disease: What Do We Know So Far?
por: Artusi, Carlo Alberto, et al.
Publicado: (2021)

Association between sleep disorders and cognitive dysfunctions in non-demented patients with advanced Parkinson’s disease
por: Montanaro, Elisa, et al.
Publicado: (2021)

SARS-CoV-2 vaccination, Parkinson’s disease, and other movement disorders: case series and short literature review
por: Imbalzano, Gabriele, et al.
Publicado: (2022)

Association of Subthalamic Deep Brain Stimulation With Motor, Functional, and Pharmacologic Outcomes in Patients With Monogenic Parkinson Disease: A Systematic Review and Meta-analysis
por: Artusi, Carlo Alberto, et al.
Publicado: (2019)

Anxiety, depression, and worries in advanced Parkinson disease during COVID-19 pandemic
por: Montanaro, Elisa, et al.
Publicado: (2021)

Peripheral Nerve Ultrasonography in Chronic Inflammatory Demyelinating Polyradiculoneuropathy and Multifocal Motor Neuropathy: Correlations with Clinical and Neurophysiological Data
por: Merola, Aristide, et al.
Publicado: (2016)

What Happens When I Watch a Ballet and I Am Dyskinetic? A fMRI Case Report in Parkinson Disease
por: Palermo, Sara, et al.
Publicado: (2020)

Should we offer deep brain stimulation to Parkinson’s disease patients with GBA mutations?
por: Artusi, Carlo Alberto, et al.
Publicado: (2023)

Short-Term Efficacy of Ultramicronized Palmitoylethanolamide in Peripheral Neuropathic Pain
por: Cocito, Dario, et al.
Publicado: (2014)

Role of the Cingulate Cortex in Dyskinesias-Reduced-Self-Awareness: An fMRI Study on Parkinson’s Disease Patients
por: Palermo, Sara, et al.
Publicado: (2018)

Deep Brain Stimulation Selection Criteria for Parkinson’s Disease: Time to Go beyond CAPSIT-PD
por: Artusi, Carlo Alberto, et al.
Publicado: (2020)

Current Directions in Deep Brain Stimulation for Parkinson’s Disease—Directing Current to Maximize Clinical Benefit
por: Merola, Aristide, et al.
Publicado: (2020)

The Current Evidence for the Use of Safinamide for the Treatment of Parkinson's Disease
por: Abbruzzese, Giovanni, et al.
Publicado: (2021)

Safety and efficacy of tolcapone in Parkinson’s disease: systematic review
por: Artusi, Carlo Alberto, et al.
Publicado: (2021)

How resistant are levodopa‐resistant axial symptoms? Response of freezing, posture, and voice to increasing levodopa intestinal infusion rates in Parkinson disease
por: Imbalzano, Gabriele, et al.
Publicado: (2022)

Environmental Exposures and Parkinson’s Disease
por: Nandipati, Sirisha, et al.
Publicado: (2016)

Assessment of Axial Postural Abnormalities in Parkinsonism: Automatic Picture Analysis Software
por: Artusi, Carlo Alberto, et al.
Publicado: (2023)

Accuracy of a Symptom-Based Approach to Identify Hypertensive Emergencies in the Emergency Department
por: Vallelonga, Fabrizio, et al.
Publicado: (2020)

Behavioral and Emotional Dysfunction in Parkinson's Disease
por: Bologna, Matteo, et al.
Publicado: (2019)

Assessing the risks of treatment in Parkinson disease psychosis: An in-depth analysis
por: Longardner, Katherine, et al.
Publicado: (2023)

Adaptive deep brain stimulation controls levodopa‐induced side effects in Parkinsonian patients
por: Rosa, Manuela, et al.
Publicado: (2017)

Cognition among individuals along a spectrum of increased risk for Parkinson’s disease
por: Chahine, Lana M., et al.
Publicado: (2018)

Camera- and Viewpoint-Agnostic Evaluation of Axial Postural Abnormalities in People with Parkinson’s Disease through Augmented Human Pose Estimation
por: Aldegheri, Stefano, et al.
Publicado: (2023)

Focal seizures with impaired awareness as long-term neurological complication of COVID-19: a case report
por: Bozzali, Marco, et al.
Publicado: (2021)

The Parkinson Care Advocate: Integrating Care Delivery
por: Sokol, Leonard L., et al.
Publicado: (2017)

Cohort study of neurological comorbidities and COVID-19-related case fatality
por: Imbalzano, Gabriele, et al.
Publicado: (2021)

Early reversible leukoencephalopathy and unilateral sixth cranial nerve palsy in mild COVID-19 infection
por: Piazza, Federico, et al.
Publicado: (2021)

Neurological comorbidities and COVID-19-related case fatality: A cohort study
por: Romagnolo, Alberto, et al.
Publicado: (2021)

Cognitive Impairment in Parkinson’s Disease: Epidemiology, Clinical Profile, Protective and Risk Factors
por: Gonzalez-Latapi, Paulina, et al.
Publicado: (2021)

Doctor–patient relationship at the time of COVID-19: travel notes
por: Vallelonga, Fabrizio, et al.
Publicado: (2020)

Hispanic Perspectives on Parkinson’s Disease Care and Research Participation
por: Damron, Lisa, et al.
Publicado: (2021)

Neurological comorbidity and severity of COVID-19
por: Romagnolo, Alberto, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_d9lmb61691vdo5njtgkh6hegb1